The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
about
Retinoic acid post consolidation therapy for high-risk neuroblastoma patients treated with autologous hematopoietic stem cell transplantationHigh-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastomaRapid COJEC versus standard induction therapies for high-risk neuroblastomaRapid COJEC versus standard induction therapies for high-risk neuroblastomaHigh-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastomaRetinoic acid post consolidation therapy for high-risk neuroblastomaMIBG scintigraphy and PET imaging for diagnosing neuroblastomaNeuroblastomaOutcome after reduced chemotherapy for intermediate-risk neuroblastomaCancer Stem Cells and Their Interaction with the Tumor Microenvironment in NeuroblastomaNatural killer cells and neuroblastoma: tumor recognition, escape mechanisms, and possible novel immunotherapeutic approachesNeuroblastoma and nephroblastoma: a radiological reviewTumors of the neural crest: Common themes in development and cancerPreclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastomaCASP8 SNP D302H (rs1045485) is associated with worse survival in MYCN-amplified neuroblastoma patients.Molecular pathogenesis of peripheral neuroblastic tumorsPlasma levels of soluble HLA-E and HLA-F at diagnosis may predict overall survival of neuroblastoma patientsA p53 drug response signature identifies prognostic genes in high-risk neuroblastomaTL-118 and gemcitabine drug combination display therapeutic efficacy in a MYCN amplified orthotopic neuroblastoma murine model--evaluation by MRICombined Scintigraphy and Tumor Marker Analysis Predicts Unfavorable Histopathology of Neuroblastic Tumors with High AccuracyOverview and recent advances in the treatment of neuroblastoma.Neuroblastoma, a Paradigm for Big Data Science in Pediatric Oncology.PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastomaTh-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.Multiscale integration of -omic, imaging, and clinical data in biomedical informatics.Acquired genetic alterations in tumor cells dictate the development of high-risk neuroblastoma and clinical outcomesFeasibility of Administering High-Dose (131) I-MIBG Therapy to Children with High-Risk Neuroblastoma Without Lead-Lined Rooms.11q deletion in neuroblastoma: a review of biological and clinical implications.Research progress of neuroblastoma related gene variations.Array-based gene expression, CGH and tissue data defines a 12q24 gain in neuroblastic tumors with prognostic implication.Integrating cell-based and clinical genome-wide studies to identify genetic variants contributing to treatment failure in neuroblastoma patientsGlycobiology of neuroblastoma: impact on tumor behavior, prognosis, and therapeutic strategies.A c-Myc-regulated stem cell-like signature in high-risk neuroblastoma: A systematic discovery (Target neuroblastoma ESC-like signature).Screening a panel of drugs with diverse mechanisms of action yields potential therapeutic agents against neuroblastoma.Incorporation of high-dose 131I-metaiodobenzylguanidine treatment into tandem high-dose chemotherapy and autologous stem cell transplantation for high-risk neuroblastoma: results of the SMC NB-2009 studyHigh-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset.Metastatic congenital neuroblastoma associated with in situ neuroblastoma: case report and review of literature.Transcriptional co-activator with PDZ-binding motif overexpression promotes cell proliferation and transcriptional co-activator with PDZ-binding motif deficiency induces cell cycle arrest in neuroblastoma.Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma.
P2860
Q24186451-45D08FEF-8EC4-43CB-9505-B8D973FD10EEQ24186636-84B8923B-5873-40B5-9983-9BCF30840A91Q24186888-94A32450-6A1A-40FD-9DDD-E5F8BAD05294Q24187922-C6373A89-1555-4BE2-8450-C08D43684E36Q24197871-D8175903-C921-42C8-BCDD-A07D879EEA37Q24200296-B7B6CC4B-C410-4D78-8992-AAD2F2DEF23EQ24201495-16838908-C1FB-45B5-B8ED-9BEA25C67313Q24234571-45526F3B-4CF1-47F6-9345-82066175F2CFQ24617733-08C4E2D5-ACFE-4510-A1DB-AAFAB0B0F71EQ24633964-AEFDF97E-A045-4FFB-8223-4D9B158FDB08Q26771238-C4295672-3817-41BB-BDED-86C3341410C1Q26825652-8A996B10-8E9F-467E-A7DE-A133BCB1FD83Q26861867-00E77FF2-AC7E-4044-BF82-8CBB067E9C54Q26864763-526F9398-4D82-4166-A713-A3E740943405Q27303714-6900C235-D90B-4443-8422-AE1D62D13694Q27853102-ADDEE7B9-30A3-4B90-9891-E3FB2545B5A7Q28271405-0F47DA2F-F6BA-4E53-A200-E589B92AC720Q28304289-6131A4F1-4E59-4924-933A-C97600F71195Q28537647-C2C2B1ED-345D-4217-898A-7D98A9B139E7Q28540575-1791AFA7-88A5-4AC7-97AF-BF3CDB90D57AQ28546522-9B68895C-7861-459F-9491-E7E3800AFE1DQ30238693-1254B2F4-BFFD-48AE-812E-5FE5C3CC4E21Q30239861-8CC5D9F1-87B3-4707-9D41-3496889C69B2Q30417536-BE976DD2-E8A3-4C94-A629-5B5AA80922FDQ30541198-DAB236A5-B259-48A5-BA70-333B0F48CAEEQ30581136-B71BDA88-B35E-44A3-ACB1-9BAC05F03594Q30657233-298FF1ED-AEED-4914-8968-D8E003148A27Q30730580-4D96AFFC-FDA4-4D30-8BAC-18E734110851Q32174267-3056A6AA-F72D-4E20-87D8-D31E11600944Q33566987-8C6F3739-B688-4C29-819F-E2E00FEAAAA3Q33571656-F8B6A530-1B92-473D-B834-753C7139A57FQ33645629-3C8F1A7C-B494-4CA6-97EE-830AFB33F5C8Q33659849-5A9FEDCB-F47A-4069-A1B7-4454EEEF1C1AQ33669451-B43D7580-FAE6-480B-9B24-657CEE3C582CQ33691241-075AF7E6-D333-48A0-A661-F4BED211F638Q33691441-735E46B1-C26E-400A-857C-7E5B9B88D163Q33732709-1AB90D4F-FF8B-4B09-9598-274245B9F173Q33738022-13F0DA94-BCF1-4FC8-B2E7-D627B6DB5370Q33751099-F43EFFF2-FBC4-4B7E-9DBD-87E71A2802D6Q33757079-649694F1-2BF1-40BC-9CB3-24A4D37786AF
P2860
The International Neuroblastoma Risk Group (INRG) classification system: an INRG Task Force report.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
The International Neuroblastom ...... em: an INRG Task Force report.
@en
type
label
The International Neuroblastom ...... em: an INRG Task Force report.
@en
prefLabel
The International Neuroblastom ...... em: an INRG Task Force report.
@en
P2093
P2860
P50
P356
P1476
The International Neuroblastom ...... em: an INRG Task Force report.
@en
P2093
Andreas Faldum
Andrew D J Pearson
Barbara Hero
David Machin
Garrett M Brodeur
INRG Task Force
Katherine K Matthay
Thorsten Simon
Tom Monclair
Tomoko Iehara
P2860
P304
P356
10.1200/JCO.2008.16.6785
P407
P577
2008-12-01T00:00:00Z